Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe.
Courtney DavisAnita Katharina WagnerMaximilian Salcher-KonradHenry ScowcroftBarbara J MintzesAdrian M J PokornyJianhui LewHuseyin NaciPublished in: BMJ (Clinical research ed.) (2023)
The findings of this study highlight the need to improve the communication of the benefits and related uncertainties of anticancer drugs in regulated information sources in Europe to support evidence informed decision making by patients and their clinicians.